New Joint Commission Standards BoosterPak for High-Level Disinfection (HLD) and Sterilization

On December 7, 2015, The Joint Commission published a new Standards BoosterPak™ for high-level disinfection (HLD) and sterilization in all healthcare settings.

According The Joint Commission, the new High-Level Disinfection (HLD) and Sterilization BoosterPak™ is designed to “ensure practices are carried out following regulatory standards and evidence-based guidelines for HLD and sterilization in order to minimize the potential risk of infection transmission to patients.”

Healthcare organizations accredited by The Joint Commission continue to discover serious noncompliance issues with the Infection Prevention and Control Standard IC.02.02.01. These breaches are specific to HLD of semi-critical devices and sterilization of critical devices; both pose a potential risk of infection to patients.

During accreditation surveys, organizations that perform HLD and sterilization display wide variations in their processes. Penalties from identifying HLD and/or sterilization breaches that may pose an immediate threat to life (ITL) can include an adverse accreditation decision.

Background: High-Level Disinfection (HLD) and Sterilization BoosterPak™

The new Standards BoosterPak™ looks at the primary Joint Commission standard and element of performance (EP) governing HLD and sterilization processes in the Infection Prevention and Control (IC) chapter – Standard IC.02.02.01, EP 2, and also addresses related HLD and sterilization standards in the IC, Environment of Care (EC), Human Resources (HR), Leadership (LD), and National Patient Safety Goals (NPSG) chapters.

IC.02.02.01: The hospital reduces the risk of infections associated with medical equipment, devices, and supplies.

EP 2: The hospital implements infection prevention and control activities when doing the following: Performing intermediate and high-level disinfection and sterilization of medical equipment, devices, and supplies.

The High-Level Disinfection (HLD) and Sterilization BoosterPak™ is provided as a single document, but is also divided into the following individual sections for easier reference:

  • Leadership
  • Risk Assessment
  • Sterilization
  • Environment of Care
  • High-Level Disinfection
  • HR – Competency and Training
  • Appendix – Standards

More about Standards BoosterPaks™

A Standards BoosterPak™ is a searchable document intended to provide detailed information about a single standard or topic area that has been associated with a high volume of inquiries or noncompliance scores in the healthcare field.

The BoosterPak™ concept was developed by The Joint Commission as one method to address the issue of consistency of standards interpretation. BoosterPaks™ contain a description of the standard(s) and implementation suggestions, frequently asked questions, definitions, and additional information about the specific topic, and supporting documentation, evidence, historical information, references, and links.

CDC & FDA Alert on Cleaning, Disinfecting, and Sterilizing Reusable Medical Devices

Distributed via the CDC Health Alert Network
October 2, 2015, 08:00 EST (08:00 AM EST)
CDC HAN-00383: CDC/FDA Health Update about the Immediate Need for Healthcare Facilities to Review Procedures for Cleaning, Disinfecting, and Sterilizing Reusable Medical Devices

As a follow-up to HAN 00382 (distributed September 11, 2015), the Centers for Disease Control and Prevention (CDC) and U.S. Food and Drug Administration (FDA) are providing this update (HAN 00383) to rescind the following recommendation:

“If healthcare facilities contract maintenance and repair of these devices to third-party vendors, healthcare facilities should verify that these vendors are approved or certified by the manufacturer to provide those services. We are making this change because there are currently no formal standardized programs or processes through which all manufacturers certify third-party vendors. We are also further clarifying that healthcare facilities which hire contractors to perform device reprocessing should verify that the contractor has an appropriate training program (i.e., consistent with what would be required in the healthcare facility) and that the training program includes the specific devices used by the healthcare facility.”

SUMMARY

On September 11, 2015, the CDC issued HAN 00382 alerting healthcare providers and facilities about the public health need to properly maintain, clean, and disinfect or sterilize reusable medical devices. Recent infection control lapses due to non-compliance with recommended reprocessing procedures highlight a critical gap in patient safety. Healthcare facilities (e.g., hospitals, ambulatory surgical centers, clinics, and doctors’ offices) that utilize reusable medical devices are urged to immediately review current reprocessing practices at their facility to ensure they (1) are complying with all steps as directed by the device manufacturers, and (2) have in place appropriate policies and procedures that are consistent with current standards and guidelines.

After considering feedback from vendors that perform servicing and repair of reusable medical devices, we are amending HAN Advisory 382 to remove the following sentence:

“If healthcare facilities contract maintenance and repair of these devices to third-party vendors, healthcare facilities should verify that these vendors are approved or certified by the manufacturer to provide those services.”

We are making this change because there are currently no formal standardized programs or processes through which all manufacturers certify third-party vendors. We are also further clarifying that healthcare facilities which hire contractors to perform device reprocessing should verify that the contractor has an appropriate training program (i.e., consistent with what would be required in the healthcare facility) and that the training program includes the specific devices used by the healthcare facility.

BACKGROUND

Recent media reports describe instances of patients being notified that they may be at increased risk for infection due to lapses in basic cleaning, disinfection, and sterilization of medical devices. These events involved failures to follow manufacturers’ reprocessing instructions for critical [1] and semi-critical [2] items and highlight the need for healthcare facilities to review policies and procedures that protect patients.

RECOMMENDATIONS

Healthcare facilities should arrange for a healthcare professional with expertise in device reprocessing to immediately assess their reprocessing procedures. This assessment should ensure that reprocessing is done correctly, including allowing enough time for reprocessing personnel to follow all steps recommended by the device manufacturer. The following actions should be performed:

Training

Healthcare facilities should provide training to all personnel who reprocess medical devices.

Training should be required and provided:

  • Upon hire or prior to provision of services at the facility
  • At least once a year
  • When new devices or protocols are introduced, including changes in the manufacturer’s instructions for use during the device’s life cycle

Personnel should be required to demonstrate competency with device reprocessing (i.e., trainer observes correct technique) prior to being allowed to perform reprocessing independently.

Healthcare facilities should maintain current documentation of trainings and competencies.

If the healthcare facility hires a contractor for device reprocessing, the facility should verify that the contractor has an appropriate training program (i.e., consistent with what would be required in the healthcare facility) and that the training program includes the specific devices the healthcare facility uses.

Copies of manufacturers’ instructions for operating and reprocessing each type of reusable device should be readily available to staff and inspectors. This file should include instructions for use of chemical disinfectants.

Audit and Feedback

Healthcare facilities should regularly audit (monitor and document) adherence to cleaning, disinfection, sterilization, and device storage procedures. Audits should assess all reprocessing steps, including:

  • Performing prompt cleaning after use, prior to disinfection or sterilization procedures
  • Using disinfectants in accordance with manufacturers’ instructions (e.g., dilution, contact time, storage, shelf-life)
  • Monitoring sterilizer performance (e.g., use of chemical and biological indicators, read-outs of sterilizer cycle parameters, appropriate record keeping)
  • Monitoring automated endoscope reprocessor performance (e.g., print out of flow rate, time, and temperature, use of chemical indicators for monitoring high-level disinfectant concentration)

Audits should be conducted in all areas of the facility where reprocessing occurs.

Healthcare facilities should provide feedback from audits to personnel regarding their adherence to cleaning, disinfection, and sterilization procedures.

Infection Control Policies and Procedures

Healthcare facilities should allow adequate time for reprocessing to ensure adherence to all steps recommended by the device manufacturer, including drying, proper storage, and transport of reprocessed devices.

  • Considerations should be made regarding scheduling of procedures and supply of devices to ensure adequate time is allotted for reprocessing.

Healthcare facilities should have protocols to ensure that healthcare personnel can readily identify devices that have been properly reprocessed and are ready for patient use (e.g., tagging system, storage in a designated area).

Healthcare facilities should have policies and procedures outlining facility response in the event of a recognized reprocessing error or failure. Healthcare personnel should assess the cause of the error or failure and the exposure event in order to determine the potential risk of infection. The procedure should include how patients who might have been exposed to an improperly reprocessed medical device would be identified, notified, and followed.

Individuals responsible for infection prevention and reprocessing at the healthcare facility should be consulted whenever new devices will be purchased or introduced to ensure that infection control considerations are included in the purchasing decision as well as subsequent implementation of appropriate reprocessing policies and procedures and to ensure that the recommended reprocessing equipment is available at the healthcare facility.

Healthcare facilities should maintain documentation of reprocessing activities, including maintenance records for reprocessing equipment (e.g., autoclaves, automated endoscope reprocessors, medical washers and washer-disinfectors, water treatment systems), sterilization records (physical, chemical, and biological indicator results), and records verifying high-level disinfectants were tested and replaced appropriately.

Healthcare facilities should follow manufacturer recommendations for maintenance and repair of medical devices that are used to perform reprocessing functions as well as medical devices that are reprocessed.

FOR MORE INFORMATION

Examples of relevant guidance include CDC’s Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 and guidance from the Association for the Advancement of Medical Instrumentation (AAMI). Health care administrators should work with their infection prevention personnel and accreditation organizations to ensure that all recommendations are properly implemented to protect patients and personnel.

Problems with medical device reprocessing should be reported to the FDA’s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. Download the form or call 1-800-332-1088 to request a reporting form, then complete and mail to address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. Health care personnel employed by facilities that are subject to the FDA’s user facility reporting requirements should follow the reporting procedures established by their facilities.

[1] Critical items (e.g., surgical instruments) are objects used to enter sterile tissue or the vascular system and must be cleaned and sterilized prior to reuse.
[2] Semi-critical items (e.g., endoscopes for upper endoscopy and colonoscopy, laryngoscope blades) are objects that contact mucous membranes or non-intact skin and require, at a minimum, cleaning and high-level disinfection prior to reuse

Researchers Investigate Improper High-Level Disinfection Practices During Endoscopy Procedures

Objective, Design, & Setting

In a retrospective cohort study conducted in four Veterans Affairs medical centers (VAMCs), Holodniy M, et al. (2012) sought to determine whether improper high-level disinfection practices during endoscopy procedures resulted in bloodborne viral infection transmission among veterans who underwent colonoscopy and laryngoscopy (ENT) procedures from 2003 to 2009.

Methods

Patients were identified through electronic health record searches and serotested for human immunodeficiency virus (HIV), hepatitis C virus (HCV), and hepatitis B virus (HBV). Newly discovered case patients were linked to a potential source with known identical infection, whose procedure occurred no more than 1 day prior to the case patient’s procedure. Viral genetic testing was performed for case/proximate pairs to determine relatedness.

Results

The researchers report that of 10,737 veterans who underwent endoscopy at four VAMCs, 9,879 patients agreed to viral testing. Of these, 90 patients were newly diagnosed with one or more viral bloodborne pathogens (BBPs). There were no case/proximate pairings found for patients with either HIV or HBV; 24 HCV case/proximate pairings were found, of which seven case patients and eight proximate patients had sufficient viral load for further genetic testing. Only two of these cases, both of whom underwent laryngoscopy, and their four proximates agreed to further testing. None of the four remaining proximate patients who underwent colonoscopy agreed to further testing. Mean genetic distance between the two case patients and 4 proximate patients ranged from 13.5 % to 19.1 %.

Conclusions

The investigators concluded that exposure to improperly reprocessed ENT endoscopes did not result in viral transmission in those patients who had viral genetic analysis performed. Any potential transmission of BBPs from colonoscopy remains unknown.

The complete study is available in free full text in Infection Control and Hospital Epidemiology (Vol. 33, No. 7, July 2012).